acetylcysteine has been researched along with Benign Neoplasms in 103 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (5.83) | 18.7374 |
1990's | 8 (7.77) | 18.2507 |
2000's | 39 (37.86) | 29.6817 |
2010's | 42 (40.78) | 24.3611 |
2020's | 8 (7.77) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Arellano, ML; Boggon, TJ; Brat, DJ; Chen, GZ; Chen, J; Chen, PR; DeBerardinis, RJ; Elf, S; Fan, J; Gu, TL; He, C; Hitosugi, T; Hurwitz, SJ; Ji, Q; Jiang, L; Kang, HB; Kang, S; Khoury, HJ; Khuri, FR; Lee, BH; Lei, Q; Li, Y; Lin, R; Lonial, S; Mao, H; Mitsche, M; Seo, JH; Shan, C; Sudderth, J; Tucker, M; Wang, D; Wu, S; Xie, J; Ye, K; Zhang, L; Zhang, S; Zhou, L | 1 |
Collado, JA; Delgado, G; Egas, V; Méndez-Cuesta, CA; Millán, E; Muñoz, E; Ramírez-Apan, T | 1 |
Dong, YL; Hu, TX; Huo, JF; Ke, Y; Li, LL; Li, YF; Liu, HM; Liu, XJ; Wang, C; Zhang, XY; Zhao, JZ | 1 |
Awasthi, S; Garg, R; Horne, D; Salgia, R; Singhal, S; Singhal, SS | 1 |
Cai, C; Han, Y; He, X; Hu, X; Kang, H; Liu, S; Liu, Y; Ma, X; Pan, T; Qi, J; Tang, Y; Wu, D; Yao, Y; Zhang, Z; Zhou, M | 1 |
Chi, YY; Eisenberg, LS; Freyer, DR; Knight, KR; Malvar, J; Mena, V; Muldoon, LL; Neely, M; Neuwelt, EA; Orgel, E; Rassekh, SR; Ross, CJD; Rushing, T; Scott, EN | 1 |
Borges, ID; Kenari, F; Molnár, S; Napolitano, HB; Perjési, P | 1 |
Lugli, E; Pilipow, K; Scamardella, E | 1 |
Duconge, J; Gonzalez, MJ; Minich, DM; Morales-Borges, RH | 1 |
Büyük, B; Coşkun, Ö; Öztopuz, Ö | 1 |
Chen, X; Miao, X; Wen, H; Yin, S; Zhang, X | 1 |
Choi, YJ; Lee, J; Lee, YS; Park, WY; Seo, SW; Shim, DM | 1 |
Baccarelli, AA; Bartolucci, GB; Byun, HM; Carrieri, M; Guo, L; Jiménez-Garza, O; Zhong, J | 1 |
Butera, G; Butturini, E; Caraglia, M; Cavallini, C; Coan, M; Cordani, M; Dando, I; Donadelli, M; Gaidano, G; Gasperini, S; Mariotto, S; Nadal-Serrano, M; Oliver, J; Oppici, E; Pacchiana, R; Roca, P; Rossi, D; Scupoli, MT; Spizzo, R; Tamassia, N; Torrens-Mas, M | 1 |
Juránek, I; Rapta, P; Šoltés, L; Valachová, K; Valent, I | 1 |
Cho, SG; Im, KI; Jeon, YW; Kim, N; Lee, ES; Lim, JY; Nam, YS; Song, Y | 1 |
Belcastro, E; Bussolati, O; Chiu, M; Corti, A; Dominici, S; Pacini, S; Piaggi, S; Pompella, A; Taurino, G | 1 |
Crump, A; Ōmura, S | 1 |
Acar, HY; Ari, F; Buz, PT; Demirci, G; Duman, FD; Erkisa, M; Ulukaya, E | 1 |
Bollinger, J; Budhraja, A; Craig, J; Lang, WH; Ling, T; Maier, J; Marsico, TD; Opferman, J; Potts, MB; Rivas, F | 1 |
Brock, P; Cabral, S; Freyer, DR; Knight, K; Reaman, G; Robinson, PD; Sung, L | 1 |
Basile, A; Mazzone, A; Morello, S; Pellecchia, C; Strianese, M; Turco, MC | 1 |
Hanly, L; Huang, SH; Koren, G; Regueira, O; Rieder, MJ; Shah, RK; Vasylyeva, TL | 1 |
Amoscato, A; Celis, E; Condamine, T; Gabrilovich, DI; Johnson, JJ; Kagan, VE; Klein-Seetharaman, J; Mohammadyani, D; Ramakrishnan, R; Tuyrin, VA; Tyurin, VA; Veglia, F; Zhang, LM | 1 |
Gutierrez, E; Jansson, PJ; Richardson, DR | 1 |
Hua, Y; Xie, AM; Yuan, J; Zhang, W; Zhu, HY; Zhu, JP | 1 |
Krivitsky, A; Polyak, D; Satchi-Fainaro, R; Scomparin, A | 1 |
Cai, S; Gao, Y; Qu, L; She, T; Shou, C; Su, Y; Wang, L; Xu, S; Zhao, C | 1 |
Bjørn, ME; Hasselbalch, HC | 1 |
Butterworth, KT; Currell, FJ; McMahon, SJ; Prise, KM; Schettino, G; Taggart, LE | 1 |
Cheng, WH; Gong, MY; Liu, XX; Wang, YN; You, H; Zhang, X; Zhu, JH; Zhu, JJ; Zou, M | 1 |
Akao, Y; Kumazaki, M; Kuranaga, Y; Shinohara, H; Sugito, N; Takai, T; Taniguchi, K | 1 |
Aldinucci, D; Altaf, M; Borghese, C; Casagrande, N; Celegato, M; Corona, G; Isab, AA; Kawde, AN; Larcher, R; Monim-Ul-Mehboob, M; Ogasawara, M; Siddik, ZH | 1 |
Abdel-Qadir, H; Amir, E; Fazelzad, R; Lee, DS; Ong, G; Thavendiranathan, P; Tomlinson, G | 1 |
Chen, D; Dou, QP; Landis-Piwowar, KR; Milacic, V; Yang, H | 1 |
Amantini, C; Bramucci, M; Buonanno, F; Iio, H; Lucciarini, R; Ortenzi, C; Quassinti, L; Santoni, G | 1 |
Berg, JZ; Hecht, SS; Hochalter, JB | 1 |
Tsukamoto, S; Yokosawa, H | 1 |
Millea, PJ | 1 |
Gu, H; Guo, Q; Liu, W; Lu, N; Mu, R; Qi, Q; Rong, J; Wang, J; Yang, Y; You, Q | 1 |
Cavalieri, EL; Rogan, EG | 1 |
Bulut, D; Chromik, AM; Daigeler, A; Flier, A; Hahn, SA; Harati, K; May, C; Mittelkötter, U; Ritter, PR; Roschinsky, J; Sülberg, D; Uhl, W | 1 |
Benbrook, DM; Ding, WQ; Hanigan, MH; Lind, SE; Lou, JR; Zhang, XX; Zheng, J | 1 |
Filatova, NA; Gamaleĭ, IA; Kirpichnikova, KM; Vakhromova, EA | 1 |
Dai, XM; Gao, J; Guo, WJ; Li, WB; Liu, HL; Wang, CH; Xu, JJ; Yao, QZ | 1 |
Du, J; King, I; Nassar, AE | 1 |
Bershteĭn, LM; Boiarkina, MP; Kovalenko, IG; Kovalevskiĭ, AIu; Poroshina, TE; Revskoĭ, SIu; Vasil'ev, DA | 1 |
Akitaya, T; Kamiie, K; Kidachi, Y; Noshita, T; Ryoyama, K; Umetsu, H; Yamaguchi, H; Yoshida, K; Yu, T | 1 |
Dozias, S; Gosset, D; Kieda, C; Legrain, B; Lerondel, S; Pape, AL; Pouvesle, JM; Ries, D; Robert, E; Sarron, V; Sobilo, J; Vandamme, M | 1 |
Cramer, JM; Jeffery, EH; Teran-Garcia, M | 1 |
Gu, W; Silverman, RB | 1 |
Alladin, KP; Igbokwe, O; Nakayama, A; White, JD | 1 |
Awasthi, S; Awasthi, YC; Chaudhary, P; Kokate, RA; Kumar, S; Sahu, M; Sharma, R | 1 |
Achilefu, S; Akers, W; Cao, J; Deng, DW; Gu, YQ; Li, X; Liu, F; Xue, B | 1 |
Costanzo, C; Dalla Pozza, E; Dando, I; Donadelli, M; Fiorini, C; Menegazzi, M; Palmieri, M; Sgarbossa, A | 1 |
Ávalos Fúnez, A; Isabel Haza, A; Mateo, D; Morales, P | 1 |
Choi, YK; Kim, DG; Liu, MJ; Won, YS; You, KR | 1 |
Boehncke, WH; Elliott, PJ; Zollner, TM | 1 |
Bae, GU; Cho, EJ; Choi, WS; Han, JW; Han, SH; Jung, DK; Kang, H; Kim, YK; Lee, HW; Lee, HY; Seo, DW | 1 |
Harris, RC; Singh, AB | 1 |
Chiao, JW; Chung, FL; Conaway, CC; Liu, D; Ramaswamy, G; Wang, L; Wu, H | 1 |
Yildiz, D | 1 |
Barrett, JC; French, JE; Honeycutt, HP; Jokinen, MP; Kari, FW; Martin, KR; Quinn, A | 1 |
Goto, R; Ibuki, Y | 1 |
Beckett, MA; Hellman, S; Kimchi, ET; Kufe, DW; Lopez, CA; Mauceri, HJ; Mehta, N; Murphy, KT; Park, JO; Posner, MC; Weichselbaum, RR | 1 |
Daniel, KG; Dou, QP; Kazi, A; Kuhn, DJ | 1 |
Aitio, ML | 1 |
Albertsson, P; Lennernäs, B; Norrby, K | 1 |
Balansky, R; Croce, CM; D'Agostini, F; De Flora, S; Di Marco, B; Ganchev, G; Izzotti, A; Lubet, RA; Zanesi, N | 1 |
Matkovics, A | 1 |
Hemann, CF; Hille, R; Horan, MP; Mallery, SR; Pei, P; Schwendeman, SP | 1 |
Awasthi, S; Singhal, SS; Yadav, S; Zajac, E | 1 |
Khashab, M; Kwo, PY; Tector, AJ | 1 |
Chesselet, MF; Fleming, SM; Reliene, R; Schiestl, RH | 1 |
Barkholt, L; Brune, M; Fransson, K; Hassan, M; Hassan, Z; Karlsson, H; Mattsson, J; Omazic, B; Remberger, M; Ringdén, O; Svahn, BM | 1 |
Ishimi, Y; Takezawa, J; Yamada, K | 1 |
Bauer, JA; Belbin, TJ; Bradford, CR; Brenner, JC; Carey, TE; Prystowsky, MB; Sikora, MJ; Soengas, MS; Taylor, JC; Verhaegen, M; Wang, S | 1 |
Hecht, SS; Hochalter, JB; Villalta, PW | 1 |
Bonow, R; Corden, B; Doroshow, J; Epstein, S; Jenkins, J; Locker, G; Myers, C; Palmeri, S | 1 |
Muggia, FM | 1 |
Anderson, T; Duelge, J; Hansen, RM; Holoye, PY; Ritch, PS | 1 |
Alberts, DS; Boone, CW; Covey, JM; Crowell, JA; Doody, LA; Greenwald, P; Kelloff, GJ; Knapp, GG; Lubet, RA; Steele, VE | 1 |
Balansky, RM; D'Agostini, F; De Flora, S; Izzotti, A; Rossi, GA | 1 |
Feldstein, TJ; Hartfield, D; Horner, H; Kobrinsky, NL; Maksymiuk, A; Minuk, GY; White, DF | 1 |
Aeschbacher, B; Fikrle, A; Fluri, M; Meier, B; Wagdi, P | 1 |
Bockstette, M; Dröge, W; Galter, D; Gross, A; Hack, V; Kinscherf, R; Mihm, S; Schykowski, M | 1 |
Bärtsch, P; Benner, A; Breitkreutz, R; Dröge, W; Hack, V; Kinscherf, R; Röhrer, H; Taut, F | 1 |
Clarke, DM; Loo, TW | 1 |
Macciò, A; Mantovani, G; Massa, E; Melis, G; Mudu, MC; Mura, L | 1 |
An, WG; Blagosklonny, MV; Hwang, SG; Trepel, JB | 1 |
Ashok, BT; Kim, E; Mittelman, A; Tiwari, RK | 1 |
Elliott, PJ; Ross, JS | 1 |
Moyad, MA | 1 |
Albini, A; De Flora, S; Ferrari, N; Tosetti, F | 1 |
Baas, P; Balm, AJ; Bast, A; Besarati Nia, A; Besaratinia, A; Camoirano, A; D'Agostini, F; Dallinga, JW; De Flora, S; Haenen, GR; Izzotti, A; Sakai, H; Van Schooten, FJ; Van Zandwijk, N; Van't Veer, L | 1 |
Brash, DE; Havre, PA; McCormick, JJ; O'Reilly, S | 1 |
Reboud-Ravaux, M | 1 |
Domingo, P; Martinez, E | 1 |
Bodey, GP; Ho, DH; LeBlanc, B; Rolston, KV | 1 |
Schreiber, EC | 1 |
26 review(s) available for acetylcysteine and Benign Neoplasms
Article | Year |
---|---|
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Humans; Lipogenesis; Neoplasms; Oxidative Stress; Pentose Phosphate Pathway; Phosphogluconate Dehydrogenase; Protein Serine-Threonine Kinases; Ribulosephosphates; Signal Transduction | 2015 |
RLIP: A necessary transporter protein for translating oxidative stress into pro-obesity and pro-carcinogenic signaling.
Topics: Acetylcysteine; Adipokines; Animals; Carcinogenesis; Carcinogens; Carrier Proteins; Clathrin; Cytokines; Epidermal Growth Factor; GTPase-Activating Proteins; Humans; Infant; Insulins; Male; Mice; Neoplasms; Obesity; Oxidative Stress; Peptide Hormones; Transforming Growth Factor beta; Tumor Suppressor Protein p53 | 2022 |
N-Acetyl Cysteine and Glutathione in Health and Cancer-Pharmacogenomics, Research, and Clinical Practice: Hypothesis and Review.
Topics: Acetylcysteine; Antineoplastic Agents; Antioxidants; Glutathione; Humans; Neoplasms; Pharmacogenetics; Sulfhydryl Compounds | 2022 |
Lactacystin: first-in-class proteasome inhibitor still excelling and an exemplar for future antibiotic research.
Topics: Acetylcysteine; Antibiotics, Antineoplastic; Biological Products; Dementia; Drug Discovery; Humans; Neoplasms; Neuroprotective Agents; Proteasome Inhibitors | 2019 |
Interventions for cisplatin-induced hearing loss in children and adolescents with cancer.
Topics: Acetylcysteine; Adolescent; Amifostine; Anti-Inflammatory Agents; Antineoplastic Agents; Chelating Agents; Child; Cisplatin; Cytoprotection; Dexamethasone; Disulfiram; Ditiocarb; Humans; Neoplasms; Ototoxicity; Thiosulfates | 2019 |
Achieving successful delivery of oligonucleotides--From physico-chemical characterization to in vivo evaluation.
Topics: Acetylcysteine; Animals; Dendrimers; Drug Delivery Systems; Drug Evaluation, Preclinical; Hepatitis; HIV Infections; Humans; MicroRNAs; Microscopy; Neoplasms; Neurodegenerative Diseases; Oligonucleotides; RNA Interference; Static Electricity | 2015 |
The Role of Reactive Oxygen Species in Myelofibrosis and Related Neoplasms.
Topics: Acetylcysteine; Animals; Antioxidants; Disease Progression; Hepatitis C; Humans; Inflammation; Mice; Myeloproliferative Disorders; Neoplasms; Oxidative Stress; Primary Myelofibrosis; Reactive Oxygen Species; Signal Transduction | 2015 |
Interventions for preventing cardiomyopathy due to anthracyclines: a Bayesian network meta-analysis.
Topics: Acetylcysteine; Adrenergic beta-Antagonists; Angiotensins; Anthracyclines; Cardiomyopathies; Clinical Trials as Topic; Dexrazoxane; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Neoplasms; Network Meta-Analysis; Prenylamine; Ventricular Dysfunction, Left | 2017 |
Natural compounds with proteasome inhibitory activity for cancer prevention and treatment.
Topics: Acetylcysteine; Animals; Anticarcinogenic Agents; Antineoplastic Agents; Boronic Acids; Bortezomib; Clinical Trials as Topic; Curcumin; Humans; Neoplasms; Pentacyclic Triterpenes; Protease Inhibitors; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Pyrazines; Triterpenes; Ubiquitin | 2008 |
Targeting the proteasome pathway.
Topics: Acetylcysteine; Animals; Antineoplastic Agents; Biological Products; Boronic Acids; Bortezomib; Drug Delivery Systems; Drug Discovery; Humans; Lactones; Neoplasms; Peptides; Protease Inhibitors; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Pyrazines; Pyrroles; Structure-Activity Relationship; Ubiquitin; Ubiquitin-Activating Enzymes; Ubiquitins | 2009 |
N-acetylcysteine: multiple clinical applications.
Topics: Acetaminophen; Acetylcysteine; Antidotes; Expectorants; Female; Free Radical Scavengers; Hearing Loss; Humans; Influenza, Human; Neoplasms; Polycystic Ovary Syndrome; Respiratory Tract Diseases | 2009 |
Depurinating estrogen-DNA adducts in the etiology and prevention of breast and other human cancers.
Topics: Acetylcysteine; Animals; Antineoplastic Agents; Antioxidants; Breast Neoplasms; DNA Adducts; Estrogens; Female; Humans; Male; Neoplasms; Resveratrol; Stilbenes | 2010 |
Systematic review: generating evidence-based guidelines on the concurrent use of dietary antioxidants and chemotherapy or radiotherapy.
Topics: Acetylcysteine; Antioxidants; Evidence-Based Practice; Glutathione; Humans; Neoplasms; Practice Guidelines as Topic; Vitamin E | 2011 |
Inhibition of mercapturic acid pathway-mediated disposal of 4-hydroxynonenal causes complete and sustained remission of human cancer xenografts in nude mice.
Topics: Acetylcysteine; Aldehydes; Animals; ATP-Binding Cassette Transporters; Carcinogens, Environmental; Chemoprevention; Glutathione Transferase; GTPase-Activating Proteins; Humans; Metabolic Networks and Pathways; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms; Remission Induction; Xenobiotics | 2011 |
Proteasome inhibition: a new anti-inflammatory strategy.
Topics: Acetylcysteine; Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Arthritis, Rheumatoid; Asthma; Boronic Acids; Bortezomib; Clinical Trials as Topic; Cysteine Endopeptidases; Disease Models, Animal; Humans; Inflammation; Lysine; Models, Biological; Models, Chemical; Multienzyme Complexes; Multiple Sclerosis; Neoplasms; NF-kappa B; Peptides; Protease Inhibitors; Proteasome Endopeptidase Complex; Psoriasis; Pyrazines; Reperfusion Injury | 2003 |
Anti-angiogenic and anti-tumor properties of proteasome inhibitors.
Topics: Acetylcysteine; Angiogenesis Inhibitors; Antineoplastic Agents; Boronic Acids; Bortezomib; Humans; Neoplasms; Neovascularization, Pathologic; Protease Inhibitors; Proteasome Inhibitors; Pyrazines | 2005 |
N-acetylcysteine -- passe-partout or much ado about nothing?
Topics: Acetylcysteine; Anti-HIV Agents; Antioxidants; Cardiovascular Diseases; Drug Therapy, Combination; Expectorants; HIV Infections; Humans; Kidney Diseases; Liver Diseases; Lung Diseases; Neoplasms; Oxidative Stress; Reactive Oxygen Species | 2006 |
[Recent changes in concepts of antioxidant treatment].
Topics: Acetylcysteine; Allopurinol; Antioxidants; Apoptosis; Ascorbic Acid; Cardiovascular Diseases; Clinical Trials as Topic; Coenzymes; Flavonoids; Humans; Meta-Analysis as Topic; Neoplasms; Selenium; Ubiquinone; Vitamin A; Vitamin D; Vitamin E; Vitamin K; Vitamins | 2006 |
Linking stress-signaling, glutathione metabolism, signaling pathways and xenobiotic transporters.
Topics: Acetylcysteine; ATP-Binding Cassette Transporters; Drug Resistance, Neoplasm; Endocytosis; Glutathione; GTPase-Activating Proteins; Humans; Lipid Peroxidation; Neoplasms; Radiation Protection; Signal Transduction | 2007 |
Epidemiology of acute liver failure.
Topics: Acetaminophen; Acetylcysteine; Analgesics, Non-Narcotic; Drug-Related Side Effects and Adverse Reactions; Free Radical Scavengers; Hepatitis, Autoimmune; Hepatitis, Viral, Human; Humans; Liver Failure, Acute; Liver Transplantation; Metabolic Diseases; Neoplasms; Prognosis; Vascular Diseases | 2007 |
Role of cysteine and glutathione in HIV infection and cancer cachexia: therapeutic intervention with N-acetylcysteine.
Topics: Acetylcysteine; Amino Acids; Cachexia; Cysteine; Glutathione; HIV Infections; Humans; Muscle, Skeletal; Neoplasms | 1997 |
The proteasome: a new target for novel drug therapies.
Topics: Acetylcysteine; Animals; Antineoplastic Agents; Boronic Acids; Bortezomib; Carcinoma, Lewis Lung; Clinical Trials, Phase I as Topic; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Disease Models, Animal; Humans; Multienzyme Complexes; Neoplasms; Proteasome Endopeptidase Complex; Pyrazines | 2001 |
Results and lessons from clinical trials using dietary supplements for cancer: direct and indirect investigations.
Topics: Acetylcysteine; Amygdalin; Antioxidants; Ascorbic Acid; beta Carotene; Dietary Supplements; Disease Progression; Humans; Neoplasms; Randomized Controlled Trials as Topic; Selenium; Tissue Extracts; Vitamin A; Vitamin E | 2001 |
Angioprevention': angiogenesis is a common and key target for cancer chemopreventive agents.
Topics: Acetylcysteine; Angiogenesis Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Catechin; Flavonoids; Humans; Models, Biological; Neoplasms; Neovascularization, Pathologic; Protease Inhibitors; Receptors, Cytoplasmic and Nuclear | 2002 |
Proteasome inhibitors.
Topics: Acetylcysteine; Animals; Coumarins; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Drug Design; Humans; Hydrolysis; Inflammation; Isocoumarins; Macromolecular Substances; Molecular Weight; Multienzyme Complexes; Neoplasms; Peptides; Proteasome Endopeptidase Complex; Substrate Specificity | 2002 |
Metabolically oxygenated compounds: formation, conjugation, and possible biological implications.
Topics: Acetylcysteine; Alcohols; Animals; Biotransformation; Ethers, Cyclic; Glucuronates; Half-Life; Humans; Hydro-Lyases; Hydroxylation; Mixed Function Oxygenases; Morphine; Mutation; Neoplasms; Nitrogen; Oxides; Oxygen Consumption; Oxygenases; Pharmaceutical Preparations; Phenols; Phenylacetates; Species Specificity; Sulfates; Uracil Nucleotides | 1974 |
10 trial(s) available for acetylcysteine and Benign Neoplasms
Article | Year |
---|---|
Conditioning therapy with N-acetyl-L-cysteine, decitabine and modified BUCY regimen for myeloid malignancies patients prior to allogeneic hematopoietic stem cell transplantation.
Topics: Acetylcysteine; Behavior Therapy; Busulfan; Decitabine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Myeloproliferative Disorders; Neoplasms; Prospective Studies; Reactive Oxygen Species; Transplantation Conditioning | 2023 |
Intravenous N-Acetylcysteine to Prevent Cisplatin-Induced Hearing Loss in Children: A Nonrandomized Controlled Phase I Trial.
Topics: Acetylcysteine; Administration, Intravenous; Adolescent; Child; Cisplatin; Hearing Loss; Humans; Neoplasms | 2023 |
[Influence of metformin and N-acetylcysteine on hormonal and genotoxic effects of estrogens and glucose in convalescent cancer patients].
Topics: Acetylcysteine; Aged; Blood Glucose; Body Mass Index; Breast Neoplasms; Colonic Neoplasms; Drug Administration Schedule; Endometrial Neoplasms; Estrogens; Female; Free Radical Scavengers; Glucose; Humans; Hypoglycemic Agents; Interleukin-6; Metformin; Middle Aged; Neoplasms; Postmenopause; Treatment Outcome; Tumor Necrosis Factor-alpha | 2010 |
Enhancing sulforaphane absorption and excretion in healthy men through the combined consumption of fresh broccoli sprouts and a glucoraphanin-rich powder.
Topics: Absorption; Acetylcysteine; Adolescent; Adult; Anticarcinogenic Agents; Biomarkers; Brassica; Cross-Over Studies; Diet; Dietary Supplements; Glucosinolates; Humans; Hydrolysis; Imidoesters; Isothiocyanates; Male; Neoplasms; Nutritional Sciences; Oximes; Powders; Sulfoxides; Surveys and Questionnaires; Young Adult | 2012 |
A prospective randomized study using N-acetyl-L-cysteine for early liver toxicity after allogeneic hematopoietic stem cell transplantation.
Topics: Acetylcysteine; Adolescent; Adult; Aged; Aspartate Aminotransferases; Bilirubin; Child; Child, Preschool; Female; Free Radical Scavengers; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Humans; Male; Middle Aged; Neoplasms; Prospective Studies; Time Factors; Transplantation, Homologous | 2008 |
A randomized controlled trial assessing the prevention of doxorubicin cardiomyopathy by N-acetylcysteine.
Topics: Acetylcysteine; Adolescent; Adult; Aged; Cardiomyopathies; Clinical Trials as Topic; Doxorubicin; Drug Therapy, Combination; Electrocardiography; Female; Humans; Male; Middle Aged; Nausea; Neoplasms; Patient Compliance; Random Allocation; Stroke Volume | 1983 |
Treatment of advanced malignancies with high-dose acetaminophen and N-acetylcysteine rescue.
Topics: Acetaminophen; Acetylcysteine; Adult; Aged; Antineoplastic Agents; Carcinoma, Small Cell; Drug Combinations; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms; Time Factors | 1996 |
Cardioprotection in patients undergoing chemo- and/or radiotherapy for neoplastic disease. A pilot study.
Topics: Acetylcysteine; Antineoplastic Agents; Antioxidants; Ascorbic Acid; Double-Blind Method; Heart; Humans; Neoplasms; Pilot Projects; Prospective Studies; Radionuclide Ventriculography; Radiotherapy; Radiotherapy Dosage; Stroke Volume; Vitamin E | 1996 |
The redox state as a correlate of senescence and wasting and as a target for therapeutic intervention.
Topics: Acetylcysteine; Adolescent; Adult; Aged; Aged, 80 and over; Aging; Cell Death; Child; Child, Preschool; Cystine; Female; Free Radical Scavengers; Humans; Male; Middle Aged; Neoplasms; Oxidation-Reduction; Serum Albumin; Sulfhydryl Compounds | 1998 |
Effects of oral administration of N-acetyl-L-cysteine: a multi-biomarker study in smokers.
Topics: Acetylcysteine; Administration, Oral; Adult; Anticarcinogenic Agents; Antioxidants; Biomarkers; Cotinine; DNA Adducts; DNA Damage; Double-Blind Method; Female; Free Radical Scavengers; Humans; Male; Mutagenicity Tests; Neoplasms; Smoking | 2002 |
67 other study(ies) available for acetylcysteine and Benign Neoplasms
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Effect of natural and semi-synthetic cadinanes from Heterotheca inuloides on NF-κB, Nrf2 and STAT3 signaling pathways and evaluation of their in vitro cytotoxicity in human cancer cell lines.
Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Asteraceae; Cell Line, Tumor; Cell Proliferation; Humans; Inflammation; Molecular Docking Simulation; Neoplasms; NF-E2-Related Factor 2; NF-kappa B; Polycyclic Sesquiterpenes; Sesquiterpenes; Signal Transduction; STAT3 Transcription Factor | 2017 |
Synthesis and in vitro and in vivo biological evaluation of novel derivatives of flexicaulin A as antiproliferative agents.
Topics: Acetylcysteine; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Diterpenes; Drug Screening Assays, Antitumor; Female; Humans; Membrane Potential, Mitochondrial; Mice, Inbred BALB C; Mitochondria; Molecular Structure; Neoplasms; Reactive Oxygen Species; Structure-Activity Relationship; Xenograft Model Antitumor Assays | 2020 |
(
Topics: Acetylcysteine; Antineoplastic Agents; Chalcone; Chalcones; Chromatography, High Pressure Liquid; Glutathione; Neoplasms; Sulfhydryl Compounds | 2023 |
Generating stem-like memory T cells with antioxidants for adoptive cell transfer immunotherapy of cancer.
Topics: Acetylcysteine; Antioxidants; CD8-Positive T-Lymphocytes; Cytotoxicity Tests, Immunologic; Humans; Immunologic Memory; Immunotherapy, Adoptive; Neoplasms; Stem Cells | 2020 |
Possible protective activity of n-acetyl cysteine against cisplatin‑induced hepatotoxicity in rats.
Topics: Acetylcysteine; Animals; Antineoplastic Agents; Antioxidants; Chemical and Drug Induced Liver Injury; Cisplatin; Humans; Inflammation; Liver; Neoplasms; Oxidation-Reduction; Oxidative Stress; Rats; Rats, Wistar | 2021 |
Environmental temperature affects physiology and survival of nanosecond pulsed electric field-treated cells.
Topics: Ablation Techniques; Acetylcysteine; Animals; Antioxidants; Apoptosis; Cell Line, Tumor; Cell Separation; Cell Survival; Centrifugation; Electric Stimulation; Flow Cytometry; Humans; Membrane Potential, Mitochondrial; Mice; Mitochondria; Neoplasms; Reactive Oxygen Species; Sucrose; Temperature; Time Factors | 2018 |
TP53 alteration determines the combinational cytotoxic effect of doxorubicin and an antioxidant NAC.
Topics: A549 Cells; Acetylcysteine; Antioxidants; Apoptosis; Cell Proliferation; Doxorubicin; Drug Synergism; Heart Failure; Humans; MCF-7 Cells; Neoplasms; Phosphorylation; Reactive Oxygen Species; Tumor Suppressor Protein p53 | 2017 |
Promoter methylation status in genes related with inflammation, nitrosative stress and xenobiotic metabolism in low-level benzene exposure: Searching for biomarkers of oncogenesis.
Topics: Acetylcysteine; Adult; Benzene; Biomarkers; Carcinogenesis; Cytochrome P-450 CYP2E1; DNA Methylation; Epigenesis, Genetic; Female; Humans; Inflammation; Inhalation Exposure; Interleukin-6; Male; Middle Aged; Neoplasms; Nitrosative Stress; Promoter Regions, Genetic; Xenobiotics; Young Adult | 2017 |
Mutant p53 blocks SESN1/AMPK/PGC-1α/UCP2 axis increasing mitochondrial O
Topics: Acetylcysteine; Adult; Aged; Aged, 80 and over; AMP-Activated Protein Kinases; Cell Line, Tumor; Female; Free Radical Scavengers; Heat-Shock Proteins; Humans; Male; MCF-7 Cells; Middle Aged; Mitochondria; Neoplasms; Oxygen; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Reactive Oxygen Species; Tumor Suppressor Protein p53; Uncoupling Protein 2 | 2018 |
On infusion of high-dose ascorbate in treating cancer: Is it time for N-acetylcysteine pretreatment to enhance susceptibility and to lower side effects?
Topics: Acetylcysteine; Administration, Intravenous; Antioxidants; Ascorbic Acid; Copper; Electron Spin Resonance Spectroscopy; Free Radicals; Humans; Hyaluronic Acid; Immune System; Kidney; Neoplasms; Pancreatic Neoplasms; Sulfhydryl Compounds | 2019 |
Regulation of HMGB1 release protects chemoradiotherapy-associated mucositis.
Topics: Acetylcysteine; Animals; Chemoradiotherapy; Disease Models, Animal; Female; Histones; HMGB1 Protein; Humans; Mice; Mouth Mucosa; Mucositis; Neoplasms; NF-kappa B; Organic Chemicals; Protective Agents; Protein Transport; Reactive Oxygen Species; Signal Transduction; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2019 |
γ-Glutamyltransferase enzyme activity of cancer cells modulates L-γ-glutamyl-p-nitroanilide (GPNA) cytotoxicity.
Topics: Acetylcysteine; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Survival; Enzyme Activation; gamma-Glutamyltransferase; Glutamine; Humans; Hydrolysis; Metabolic Detoxication, Phase I; Neoplasms; Reactive Oxygen Species | 2019 |
Development of near-infrared region luminescent N-acetyl-L-cysteine-coated Ag
Topics: Acetylcysteine; Antineoplastic Agents; Apoptosis; Biological Transport; Cell Line, Tumor; Cell Survival; DNA Damage; Free Radical Scavengers; Humans; Infrared Rays; Luminescence; Luminescent Agents; Neoplasms; Oxidative Stress; Particle Size; Quantum Dots; Reactive Oxygen Species; Silver Compounds; Surface Properties | 2019 |
Studies of Jatrogossone A as a Reactive Oxygen Species Inducer in Cancer Cellular Models.
Topics: Acetylcysteine; Antineoplastic Agents, Phytogenic; Antioxidants; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Humans; Jatropha; Membrane Potential, Mitochondrial; Mitophagy; Neoplasms; Poly (ADP-Ribose) Polymerase-1; Reactive Oxygen Species | 2019 |
Therapeutic potential of a pyridoxal-based vanadium(IV) complex showing selective cytotoxicity for cancer versus healthy cells.
Topics: Acetylcysteine; Caspases; Cell Death; Cell Line, Tumor; Cell Survival; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; Leukocytes, Mononuclear; Membrane Potential, Mitochondrial; Neoplasms; Pyridoxal; Reactive Oxygen Species; Tumor Stem Cell Assay; Vanadium | 2013 |
N-acetylcysteine rescue protocol for nephrotoxicity in children caused by ifosfamide.
Topics: Acetylcysteine; Animals; Antidotes; Antineoplastic Agents, Alkylating; Antioxidants; Child; Drug Administration Schedule; Humans; Ifosfamide; Kidney Diseases; Neoplasms; Quality of Life | 2013 |
Oxidized lipids block antigen cross-presentation by dendritic cells in cancer.
Topics: Acetylcysteine; Animals; Antigen Presentation; Cell Line, Tumor; Cells, Cultured; Cross-Priming; Culture Media, Conditioned; Cysteine Proteinase Inhibitors; Dendritic Cells; Flow Cytometry; Histocompatibility Antigens Class I; Histocompatibility Antigens Class II; Humans; Interferon-gamma; Lipids; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Transgenic; Microscopy, Confocal; Neoplasms; Ovalbumin; Oxidation-Reduction; Peptide Fragments | 2014 |
The anticancer agent di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT) overcomes prosurvival autophagy by two mechanisms: persistent induction of autophagosome synthesis and impairment of lysosomal integrity.
Topics: Acetylcysteine; Antineoplastic Agents; Autophagy; Cell Line, Tumor; Cell Survival; Copper; Deferoxamine; Female; Free Radical Scavengers; Humans; Iron; Lysosomes; Microtubule-Associated Proteins; Neoplasm Proteins; Neoplasms; Oxidation-Reduction; Phagosomes; Siderophores; Thiosemicarbazones | 2014 |
[Preparation and characterization of tumor targeted CdTe quantum dots modified with functional polymer].
Topics: Acetylcysteine; Cadmium Compounds; Humans; Neoplasms; Polymers; Quantum Dots; Spectrophotometry, Ultraviolet; Tellurium | 2014 |
Daucosterol inhibits cancer cell proliferation by inducing autophagy through reactive oxygen species-dependent manner.
Topics: Acetylcysteine; Adenine; Animals; Antineoplastic Agents; Apoptosis; Autophagy; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Glutathione; Humans; Mice; Neoplasms; Reactive Oxygen Species; Sitosterols; Tumor Stem Cell Assay | 2015 |
Protein disulphide isomerase as a target for nanoparticle-mediated sensitisation of cancer cells to radiation.
Topics: Acetylcysteine; Cell Line, Tumor; Cell Survival; Gene Expression Regulation, Neoplastic; Gold; Humans; Membrane Potential, Mitochondrial; Metal Nanoparticles; Mitochondria; Neoplasms; Oxidative Stress; Protein Disulfide-Isomerases; Radiation-Sensitizing Agents | 2016 |
N-acetylcysteine negatively regulates Notch3 and its malignant signaling.
Topics: Acetylcysteine; Amyloid Precursor Protein Secretases; Basic Helix-Loop-Helix Transcription Factors; Catalase; Cell Cycle Proteins; Down-Regulation; Gene Knockdown Techniques; Glutathione; HeLa Cells; Humans; Lysosomes; MCF-7 Cells; Neoplasms; Proteasome Endopeptidase Complex; Protein Domains; Reactive Oxygen Species; Receptor, Notch1; Receptor, Notch3; RNA Interference; RNA, Messenger; RNA, Small Interfering; Signal Transduction; Superoxide Dismutase; Transcription Factor HES-1 | 2016 |
Perturbation of the Warburg effect increases the sensitivity of cancer cells to TRAIL-induced cell death.
Topics: Acetylcysteine; Cell Death; Cell Line, Tumor; Cell Membrane; Cell Proliferation; Cysteine-Rich Protein 61; Gene Knockdown Techniques; Gene Silencing; Glycolysis; Heterogeneous-Nuclear Ribonucleoproteins; Humans; Neoplasms; Polypyrimidine Tract-Binding Protein; Protein Multimerization; Receptors, TNF-Related Apoptosis-Inducing Ligand; RNA, Small Interfering; TNF-Related Apoptosis-Inducing Ligand; Up-Regulation | 2016 |
New bipyridine gold(III) dithiocarbamate-containing complexes exerted a potent anticancer activity against cisplatin-resistant cancer cells independent of p53 status.
Topics: Acetylcysteine; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cisplatin; CRISPR-Cas Systems; Drug Resistance, Neoplasm; Free Radical Scavengers; Gene Knockdown Techniques; Humans; Membrane Potential, Mitochondrial; Mitochondria; Neoplasms; Organogold Compounds; Pyridines; Reactive Oxygen Species; Thiocarbamates; Tumor Suppressor Protein p53 | 2017 |
The protozoan toxin climacostol inhibits growth and induces apoptosis of human tumor cell lines.
Topics: Acetylcysteine; Apoptosis; Caspase 3; Caspase 8; Cell Proliferation; Cell Survival; DNA Fragmentation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Enzyme Activation; Humans; Membrane Potential, Mitochondrial; Neoplasms; Phosphatidylserines; Reactive Oxygen Species; Resorcinols; Time Factors; Tumor Cells, Cultured | 2008 |
Preferential glutathione conjugation of a reverse diol epoxide compared to a bay region diol epoxide of phenanthrene in human hepatocytes: relevance to molecular epidemiology studies of glutathione-s-transferase polymorphisms and cancer.
Topics: Acetylcysteine; Adult; Aged; Aged, 80 and over; Bay-Region, Polycyclic Aromatic Hydrocarbon; Female; Glutathione; Glutathione Transferase; Hepatocytes; Humans; Male; Metabolic Detoxication, Phase II; Middle Aged; Neoplasms; Phenanthrenes; Polymorphism, Genetic | 2009 |
Involvement of p53 in oroxylin A-induced apoptosis in cancer cells.
Topics: Acetylcysteine; Antineoplastic Agents; Antioxidants; Apoptosis; Blotting, Western; Cells, Cultured; Endothelium, Vascular; Flavonoids; Humans; NAD(P)H Dehydrogenase (Quinone); Neoplasms; Proto-Oncogene Proteins c-mdm2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Scutellaria baicalensis; Tumor Suppressor Protein p53; Umbilical Veins | 2009 |
Comparative analysis of cell death induction by Taurolidine in different malignant human cancer cell lines.
Topics: Acetylcysteine; Antineoplastic Agents; Caspases; Cell Death; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Glutathione; Humans; Neoplasms; Reactive Oxygen Species; Taurine; Thiadiazines | 2010 |
N-Acetylcysteine interacts with copper to generate hydrogen peroxide and selectively induce cancer cell death.
Topics: Acetylcysteine; Apoptosis; Blotting, Western; Caspase 3; Cell Line; Cell Line, Tumor; Cell Survival; Copper; Dose-Response Relationship, Drug; Humans; Hydrogen Peroxide; Microscopy, Confocal; Neoplasms; Poly(ADP-ribose) Polymerases; Reactive Oxygen Species | 2010 |
[N-acetylcysteine-induced reduction in susceptibility of transformed and embryonic cells to lytic activity of natural killer cells].
Topics: 3T3 Cells; Acetylcysteine; Actins; Animals; Cell Line, Transformed; Cell Line, Tumor; Cytotoxicity, Immunologic; Embryo, Mammalian; Fibroblasts; Humans; Killer Cells, Natural; Male; Mice; Neoplasms; Stress Fibers | 2010 |
A novel 7-azaisoindigo derivative-induced cancer cell apoptosis and mitochondrial dysfunction mediated by oxidative stress.
Topics: Acetylcysteine; Adenosine Triphosphate; Antineoplastic Agents, Phytogenic; Apoptosis; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cell Survival; Enzyme Activation; Free Radical Scavengers; Humans; Indoles; Membrane Potential, Mitochondrial; Mitochondria; Neoplasms; Osmolar Concentration; Oxidative Stress; Reactive Oxygen Species; Time Factors | 2011 |
Characterization of short-lived electrophilic metabolites of the anticancer agent laromustine (VNP40101M).
Topics: Acetylcysteine; Antineoplastic Agents; Carbon Isotopes; Chromatography, High Pressure Liquid; Cysteine; Glutathione; Humans; Hydrazines; Magnetic Resonance Spectroscopy; Microsomes, Liver; NADP; Neoplasms; Spectrometry, Mass, Electrospray Ionization; Sulfonamides | 2011 |
Selective toxicity of glycyrrhetinic acid against tumorigenic r/m HM-SFME-1 cells is potentially attributed to downregulation of glutathione.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 2; Acetylcysteine; Animals; Anti-Inflammatory Agents; Buthionine Sulfoximine; Cell Line; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Down-Regulation; Free Radical Scavengers; Glutathione; Glycyrrhetinic Acid; Inhibitory Concentration 50; Models, Molecular; Molecular Conformation; Neoplasms; Oxidation-Reduction; Protein Binding; Protein Conformation; Reactive Oxygen Species; Up-Regulation | 2011 |
ROS implication in a new antitumor strategy based on non-thermal plasma.
Topics: Acetylcysteine; Animals; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; DNA Damage; Female; HCT116 Cells; Humans; Mice; Mice, Nude; Neoplasms; Plasma Gases; Radiation, Ionizing; Reactive Oxygen Species; Transplantation, Heterologous | 2012 |
Stereospecific total syntheses of proteasome inhibitors omuralide and lactacystin.
Topics: Acetylcysteine; Apoptosis; Chemistry, Pharmaceutical; Crystallography, X-Ray; Cysteine Proteinase Inhibitors; Humans; Lactones; Magnetic Resonance Spectroscopy; Neoplasms; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Stereoisomerism | 2011 |
Synthesis of NAC capped near infrared-emitting CdTeS alloyed quantum dots and application for in vivo early tumor imaging.
Topics: Acetylcysteine; Animals; Cadmium Compounds; Cell Line, Tumor; Cell Survival; Diagnostic Imaging; Female; Human Umbilical Vein Endothelial Cells; Humans; Kidney; Liver; Lung; Mice; Mice, Nude; Microscopy, Fluorescence; Neoplasm Transplantation; Neoplasms; Quantum Dots; Sulfides; Tellurium | 2012 |
Role of mitochondrial uncoupling protein 2 in cancer cell resistance to gemcitabine.
Topics: Acetylcysteine; Apoptosis; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Drug Resistance, Neoplasm; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Ion Channels; Iridoids; Mitochondrial Proteins; Neoplasms; Poly(ADP-ribose) Polymerases; RNA, Messenger; Superoxide Dismutase; Superoxides; Uncoupling Agents; Uncoupling Protein 2 | 2012 |
In vitro evaluation of silver nanoparticles on human tumoral and normal cells.
Topics: Acetylcysteine; Antineoplastic Agents; Antioxidants; Biomarkers; Cell Membrane; Cell Survival; Cytoprotection; Dose-Response Relationship, Drug; Fibroblasts; Hep G2 Cells; HL-60 Cells; Humans; L-Lactate Dehydrogenase; Metal Nanoparticles; Mitochondria; Neoplasms; Oxidative Stress; Silver Compounds; Time Factors | 2013 |
GADD153-mediated anticancer effects of N-(4-hydroxyphenyl)retinamide on human hepatoma cells.
Topics: Acetylcysteine; Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; CCAAT-Enhancer-Binding Proteins; Cell Cycle; DNA Fragmentation; Fenretinide; Flow Cytometry; Gene Expression Profiling; Gene Expression Regulation; Genes, Reporter; Humans; Neoplasms; NF-kappa B; Sesquiterpenes; Transcription Factor CHOP; Transcription Factors; Transcription, Genetic; Tumor Cells, Cultured | 2002 |
Hydrogen peroxide mediates arsenite activation of p70(s6k) and extracellular signal-regulated kinase.
Topics: Acetylcysteine; Animals; Arsenites; Carcinogens; Catalase; Cell Line; Cell Transformation, Neoplastic; Enzyme Inhibitors; Hydrogen Peroxide; Mice; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Neoplasms; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Reactive Oxygen Species; Ribosomal Protein S6 Kinases, 70-kDa; Transcription Factor AP-1 | 2003 |
Epidermal growth factor receptor activation differentially regulates claudin expression and enhances transepithelial resistance in Madin-Darby canine kidney cells.
Topics: Acetylcysteine; Adherens Junctions; Animals; Blotting, Northern; Bromodeoxyuridine; Cell Adhesion; Cell Differentiation; Cell Division; Cell Line; Claudin-1; Claudin-3; Claudin-4; Claudins; Cycloheximide; Detergents; Dogs; Epithelium; ErbB Receptors; Gene Expression Regulation; Hepatocyte Growth Factor; Immunoblotting; Kidney; Membrane Proteins; Microscopy, Fluorescence; Neoplasms; Octoxynol; Phenotype; Protein Synthesis Inhibitors; Signal Transduction; Tight Junctions; Time Factors | 2004 |
Ingestion of an isothiocyanate metabolite from cruciferous vegetables inhibits growth of human prostate cancer cell xenografts by apoptosis and cell cycle arrest.
Topics: Acetylcysteine; Animals; Anticarcinogenic Agents; Apoptosis; Blotting, Western; Bromodeoxyuridine; Cell Cycle; Cell Cycle Proteins; Cell Division; Cell Line, Tumor; Cell Separation; Coloring Agents; Cyclin D; Cyclin E; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Cyclins; Flow Cytometry; G1 Phase; Humans; Isothiocyanates; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Mitosis; Neoplasm Transplantation; Neoplasms; Phosphorylation; Poly(ADP-ribose) Polymerases; Prostatic Neoplasms; S Phase; Time Factors; Tumor Suppressor Proteins; Up-Regulation; Vegetables | 2004 |
Inhibition of tumor growth by replacing glutathione with N-acetyl-L-cysteine.
Topics: Acetylcysteine; Animals; Antineoplastic Agents; Cell Proliferation; Glycolysis; Humans; Neoplasms; Signal Transduction | 2004 |
Tumor profile of novel p53 heterozygous Tg.AC (v-Ha-ras) bitransgenic mice treated with benzo(a)pyrene and fed dietary N-acetyl-L-cysteine (NAC).
Topics: Acetylcysteine; Animals; Anticarcinogenic Agents; Antioxidants; Benzo(a)pyrene; Carcinogens; Diet; Female; Gastric Mucosa; Genes, p53; Genes, ras; Hematologic Neoplasms; Male; Mice; Mice, Inbred Strains; Mice, Transgenic; Neoplasms; Papilloma; Pseudolymphoma; Sex Characteristics; Survival Analysis; Urinary Bladder Neoplasms | 2004 |
Dysregulation of apoptosis by benzene metabolites and their relationships with carcinogenesis.
Topics: Acetylcysteine; Animals; Apoptosis; Benzene; Benzoquinones; Caspase 3; Caspases; Cell Division; Enzyme Activation; Guanosine; Hydroquinones; Mice; Neoplasms; NIH 3T3 Cells; Reactive Oxygen Species | 2004 |
Chemoinducible gene therapy: a strategy to enhance doxorubicin antitumor activity.
Topics: Acetylcysteine; Adenoviridae; Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Combined Modality Therapy; DNA-Binding Proteins; Doxorubicin; Drug Resistance, Neoplasm; Early Growth Response Protein 1; Genetic Therapy; Genetic Vectors; Humans; Immediate-Early Proteins; Male; Neoplasms; Neovascularization, Pathologic; Promoter Regions, Genetic; Prostatic Neoplasms; Rats; Transcription Factors; Tumor Necrosis Factor-alpha; Up-Regulation; Xenograft Model Antitumor Assays | 2004 |
On metronomic chemotherapy: modulation of angiogenesis mediated by VEGE-A.
Topics: Acetylcysteine; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Dose-Response Relationship, Drug; Endothelial Cells; Male; Neoplasms; Neovascularization, Pathologic; Neovascularization, Physiologic; Oxidative Stress; Rats; Rats, Sprague-Dawley; Stem Cells; Vascular Endothelial Growth Factor A; Weight Gain | 2006 |
Influence of FHIT on benzo[a]pyrene-induced tumors and alopecia in mice: chemoprevention by budesonide and N-acetylcysteine.
Topics: Acetylcysteine; Acid Anhydride Hydrolases; Alopecia Areata; Animals; Anti-Inflammatory Agents; Benzo(a)pyrene; Budesonide; Female; Genes, Tumor Suppressor; Lung; Mice; Mice, Inbred Strains; Neoplasm Proteins; Neoplasms; Stomach | 2006 |
Reduced nonprotein thiols inhibit activation and function of MMP-9: implications for chemoprevention.
Topics: Acetylcysteine; Anticarcinogenic Agents; Catalytic Domain; Cell Line, Tumor; Chemoprevention; Enzyme Activation; Glutathione; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Models, Molecular; Neoplasms; Oxidation-Reduction; Phenylmercuric Acetate; Protein Conformation; Zinc | 2006 |
Effects of antioxidants on cancer prevention and neuromotor performance in Atm deficient mice.
Topics: Acetylcysteine; Animals; Antioxidants; Ataxia Telangiectasia Mutated Proteins; Cell Cycle Proteins; DNA-Binding Proteins; Free Radical Scavengers; Mice; Mice, Knockout; Neoplasms; Protein Serine-Threonine Kinases; Psychomotor Performance; Tumor Suppressor Proteins | 2008 |
Proteasome inhibitors remarkably prevent translesion replication in cancer cells but not normal cells.
Topics: Acetylcysteine; Boronic Acids; Caffeine; Cells, Cultured; Cisplatin; Cysteine Proteinase Inhibitors; DNA Damage; DNA Repair; DNA Replication; HeLa Cells; Humans; Leupeptins; Neoplasms; Proteasome Inhibitors; Tumor Cells, Cultured; Ultraviolet Rays | 2008 |
Anti-oxidant treatment enhances anti-tumor cytotoxicity of (-)-gossypol.
Topics: Acetylcysteine; Antineoplastic Agents; Antioxidants; Cell Line; Cell Line, Tumor; Cell Survival; Drug Synergism; Gene Expression Regulation, Neoplastic; Gossypol; Humans; Models, Biological; Neoplasms; Oligonucleotide Array Sequence Analysis; Oxidants; Reactive Oxygen Species | 2008 |
Analysis of phenanthrene diol epoxide mercapturic acid detoxification products in human urine: relevance to molecular epidemiology studies of glutathione S-transferase polymorphisms.
Topics: Acetylcysteine; Biotransformation; Carcinogens; Chromatography, High Pressure Liquid; Glutathione Transferase; Humans; Inactivation, Metabolic; Models, Molecular; Neoplasms; Phenanthrenes; Polymorphism, Genetic; Spectrometry, Mass, Electrospray Ionization | 2008 |
N-Acetylcysteine (NAC): a significant chemoprotective adjunct. Introduction.
Topics: Acetylcysteine; Antineoplastic Agents; Drug Therapy, Combination; Humans; Neoplasms | 1983 |
N-acetylcysteine (NAC): a significant chemoprotective adjunct. Proceedings of a symposium, September 8 and 10, 1982.
Topics: Acetylcysteine; Drug Therapy, Combination; Humans; Neoplasms | 1983 |
Prophylaxis of ifosfamide toxicity with oral acetylcysteine.
Topics: Acetylcysteine; Adenocarcinoma; Aged; Carcinoma, Squamous Cell; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Therapy, Combination; Hematuria; Humans; Ifosfamide; Kidney Diseases; Male; Middle Aged; Nausea; Neoplasms; Vomiting | 1983 |
Clinical development plan: N-Acetyl-l-cysteine.
Topics: Acetylcysteine; Animals; Clinical Trials as Topic; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cricetinae; Drug Approval; Drug Evaluation, Preclinical; Humans; Mice; Neoplasms; Rats | 1994 |
Pulmonary alveolar macrophages in molecular epidemiology and chemoprevention of cancer.
Topics: 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide; Acetylcysteine; Adolescent; Adult; Aged; Animals; Benzo(a)pyrene; DNA; DNA Adducts; Female; Humans; Macrophages, Alveolar; Male; Micronuclei, Chromosome-Defective; Middle Aged; Neoplasms; Rats; Rats, Sprague-Dawley; Smoking | 1993 |
The human multidrug resistance P-glycoprotein is inactive when its maturation is inhibited: potential for a role in cancer chemotherapy.
Topics: Acetylcysteine; Acquired Immunodeficiency Syndrome; Adenosine Triphosphatases; Adenosine Triphosphate; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cell Membrane; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Drug Resistance, Multiple; Glycosylation; Humans; Leupeptins; Multienzyme Complexes; Neoplasms; Proteasome Endopeptidase Complex; Protein Conformation; Protein Folding; Protein Precursors; Protein Processing, Post-Translational | 1999 |
Restoration of functional defects in peripheral blood mononuclear cells isolated from cancer patients by thiol antioxidants alpha-lipoic acid and N-acetyl cysteine.
Topics: Acetylcysteine; Adult; Aged; Antioxidants; Cell Cycle; Cytokines; fas Receptor; Flow Cytometry; Humans; Leukocytes, Mononuclear; Lymphocyte Activation; Middle Aged; Neoplasms; Nitric Oxide; Receptors, Interleukin-2; Thioctic Acid | 2000 |
Protease inhibitor-induced apoptosis: accumulation of wt p53, p21WAF1/CIP1, and induction of apoptosis are independent markers of proteasome inhibition.
Topics: Acetylcysteine; Acrylates; Amino Acid Chloromethyl Ketones; Apoptosis; Boronic Acids; Bortezomib; Calpain; Cathepsins; Cell Division; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Cysteine Endopeptidases; Drug Synergism; Genes, p53; Humans; Jurkat Cells; Leupeptins; Multienzyme Complexes; Neoplasm Proteins; Neoplasms; Oligopeptides; Protease Inhibitors; Proteasome Endopeptidase Complex; Pyrazines; Tumor Cells, Cultured; Tumor Suppressor Protein p53; U937 Cells | 2000 |
N-acetylcysteine.
Topics: Acetaminophen; Acetylcysteine; Antidotes; Expectorants; Heart Diseases; Humans; Neoplasms; Respiratory Tract Diseases | 2000 |
Proteasome inhibitors differentially affect heat shock protein response in cancer cells.
Topics: Acetylcysteine; Antigens, Neoplasm; Blotting, Western; Cell Division; Cell Line; Cell Survival; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Dose-Response Relationship, Drug; Heat-Shock Proteins; HL-60 Cells; Humans; K562 Cells; Leupeptins; Multienzyme Complexes; Neoplasms; Proteasome Endopeptidase Complex; Tumor Cells, Cultured | 2001 |
Transformed and tumor-derived human cells exhibit preferential sensitivity to the thiol antioxidants, N-acetyl cysteine and penicillamine.
Topics: Acetylcysteine; Antioxidants; Apoptosis; Cell Line; Cell Transformation, Neoplastic; Fibroblasts; Genes, myc; Humans; Neoplasms; Penicillamine; Tumor Suppressor Protein p53 | 2002 |
N-acetylcysteine as chemoprotectant in cancer chemotherapy.
Topics: Acetylcysteine; Antineoplastic Agents; Humans; Neoplasms | 1991 |
In vitro activity of paldimycin (U-70138F) against gram-positive bacteria isolated from patients with cancer.
Topics: Acetylcysteine; Bacterial Infections; Disaccharides; Glycopeptides; Gram-Positive Bacteria; Neoplasms; Vancomycin | 1987 |